Epigral Limited submits Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018 for the Quarter ended31st March, 2025.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has submitted a quarterly compliance certificate to the depositories (NSDL and CDSL) as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, filed for the quarter ended 31st March 2025, confirms that all physical share certificates received by the company from its Registrar and Transfer Agent during the quarter have been duly processed — either dematerialized into electronic form or returned to the shareholders, all within the mandated 30-day timeline. This is a standard, recurring regulatory obligation that every listed company must fulfill every quarter. There are no financial figures, no share counts, and no business developments disclosed in this filing.
No impact on shareholders or stock price. This is a routine procedural filing required by SEBI rules and carries no material information about the company's operations, financials, or strategy.